Adjudera

Awarded

INMUNOGLOBULINA HUMANA NORMAL (DOE) INTRAVENOSA al 10%

Track this recordFree account — get alerted when a contract here runs out.
Buyer
HOSPITAL CLINICO SAN CARLOS
Winners
CSL BEHRING, S.A., Octapharma, S.A., TAKEDA FARMACEUTICA ESPAÑA, S.A.
Contract value
€7,421,960
Bids received
3
Published
23 Jan 2026
Awarded
20 Jan 2026
Contract start
20 Jan 2026
Contract end
21 Jan 2027estimated
Sector
Medical equipment and pharmaceuticals
Region
Madrid
Source
Original notice on TED (55408-2026)

More awards from this buyer

AwardedBuyerWinnerContract valuePublished
SUMINISTRO, INSTALACIÓN Y PUESTA EN FUNCIONAMIENTO DE LA INFRAESTRUCTURA SUSPENDIDA Y DE LOS SISTEMAS DE INTEGRACIÓN PARA EL NUEVO BLOQUE QUIRÚRGICO DE CIRUGÍA MAYOR AMBULATORIA, EN EL HOSPITAL CLÍNICO SAN CARLOS DE MADRIDHOSPITAL CLINICO SAN CARLOSPRIM, S.A.€2,334,89616 Sept 2026
RYSTIGGO 140 MG/ML SOLUCION INYECTABLE, 1 vial de 3 mlHOSPITAL CLINICO SAN CARLOSUCB PHARMA S.A.€296,8363 Sept 2026
RYSTIGGO 140 MG/ML SOLUCION INYECTABLE, 1 vial de 2 mlHOSPITAL CLINICO SAN CARLOSUCB PHARMA S.A.€65,9373 Sept 2026
BRIVIACT 10 MG/ML SOLUCION INYECTABLE Y PARA PERFUSION 5 MLHOSPITAL CLINICO SAN CARLOSUCB PHARMA S.A.€69,930RV3 Sept 2026
BRIVIACT 10 MG/ML SOLUCION INYECTABLE Y PARA PERFUSION 5 MLHOSPITAL CLINICO SAN CARLOSUCB PHARMA S.A.€69,930RV3 Sept 2026
ABILIFY MAINTENA 720 MG POLVO Y DISOLVENTE PARA SUSPENSION DE LIBERACION PROLONGADAHOSPITAL CLINICO SAN CARLOSOTSUKA PHARMACEUTICAL S.A.€60,7371 Sept 2026